Personal information

No personal information available

Activities

Collapse all

Works (14)

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Nature genetics
2022-11 | Journal article
DOI: 10.1038/s41588-022-01211-y
PMID: 36333502
PMC: PMC9649442
Contributors: Robbe P; Ridout KE; Vavoulis DV; Dréau H; Kinnersley B; Denny N; Chubb D; Appleby N; Cutts A; Cornish AJ et al.
Source: Self-asserted source
Martí Duran-Ferrer via Europe PubMed Central

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Nature medicine
2022-08 | Journal article
DOI: 10.1038/s41591-022-01927-8
PMID: 35953718
PMC: PMC9388377
Contributors: Nadeu F; Royo R; Massoni-Badosa R; Playa-Albinyana H; Garcia-Torre B; Duran-Ferrer M; Dawson KJ; Kulis M; Diaz-Navarro A; Villamor N et al.
Source: Self-asserted source
Martí Duran-Ferrer via Europe PubMed Central

Molecular map of chronic lymphocytic leukemia and its impact on outcome.

Nature genetics
2022-08 | Journal article
DOI: 10.1038/s41588-022-01140-w
PMID: 35927489
Contributors: Knisbacher BA; Lin Z; Hahn CK; Nadeu F; Duran-Ferrer M; Stevenson KE; Tausch E; Delgado J; Barbera-Mourelle A; Taylor-Weiner A et al.
Source: Self-asserted source
Martí Duran-Ferrer via Europe PubMed Central

Chronic lymphocytic leukemias with trisomy 12 show a distinct DNA methylation profile linked to altered chromatin activation.

Haematologica
2020-12-01 | Journal article
DOI: 10.3324/haematol.2019.240721
PMID: 33256389
PMC: PMC7716362
Source: Self-asserted source
Martí Duran-Ferrer

IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.

Blood
2020-11-19 | Journal article
DOI: 10.1182/blood.2020008311
PMID: 33211804
Source: Self-asserted source
Martí Duran-Ferrer

The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome.

Nature cancer
2020-11-02 | Journal article
DOI: 10.1038/s43018-020-00131-2
PMID: 34079956
PMC: PMC8168619
Source: Self-asserted source
Martí Duran-Ferrer

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.

Blood
2020-09-01 | Journal article
DOI: 10.1182/blood.2020005289
PMID: 32584970
PMC: PMC7498364
Source: Self-asserted source
Martí Duran-Ferrer

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Genome research
2020-08-20 | Journal article
DOI: 10.1101/gr.265520.120
PMID: 32820006
PMC: PMC7545147
Source: Self-asserted source
Martí Duran-Ferrer

DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy.

Clinical epigenetics
2019-12-02 | Journal article
DOI: 10.1186/s13148-019-0783-1
PMID: 31791414
PMC: PMC6889736
Source: Self-asserted source
Martí Duran-Ferrer

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.

International journal of cancer
2019-01-15 | Journal article
DOI: 10.1002/ijc.31999
PMID: 30447004
Source: Self-asserted source
Martí Duran-Ferrer

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.

Nature medicine
2018-05-21 | Journal article
DOI: 10.1038/s41591-018-0028-4
PMID: 29785028
PMC: PMC6363101
Source: Self-asserted source
Martí Duran-Ferrer

In silico deconvolution and purification of cancer epigenomes.

Oncoscience
2017-03-01 | Journal article
DOI: 10.18632/oncoscience.346
PMID: 28540331
PMC: PMC5441471
Source: Self-asserted source
Martí Duran-Ferrer

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.

Cancer cell
2016-11-01 | Journal article
DOI: 10.1016/j.ccell.2016.09.014
PMID: 27846393
PMC: PMC5805090
Source: Self-asserted source
Martí Duran-Ferrer

Whole-genome fingerprint of the DNA methylome during human B cell differentiation.

Nature genetics
2015-06-08 | Journal article
DOI: 10.1038/ng.3291
PMID: 26053498
PMC: PMC5444519
Source: Self-asserted source
Martí Duran-Ferrer
How many people are using ORCID?